Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Beloranib

An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

Zafgen · Phase 2 · Completed · Enrollment 14

NCT02063295

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
ZGN-440 sterile diluentn/rn/rn/rn/r
ZGN-440 for injectable suspensionn/rn/rn/rn/r

Not shown

  • ZGN-440 sterile diluent: endpoint not reported
  • ZGN-440 for injectable suspension: endpoint not reported